A Fluid Challenge Test for the Diagnosis of Occult Heart Failure.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
02 2021
Historique:
received: 29 04 2020
revised: 23 07 2020
accepted: 10 08 2020
pubmed: 18 8 2020
medline: 14 9 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

A right heart catheterization with measurements of pulmonary artery wedge pressure (PAWP) may be necessary for the diagnosis of left heart failure as a cause of pulmonary hypertension or unexplained dyspnea. Diagnostic cutoff values are a PAWP of ≥ 15 mm Hg at rest or a PAWP of ≥ 25 mm Hg during exercise. However, accurate measurement of PAWP can be challenging and heart failure may be occult. Left heart catheterization, with measurement of left ventricular end-diastolic pressure, may also be indecisive. Measurements are then best repeated in stress conditions. Exercise is an option, but the equipment is not universally available, and interpretation can be difficult in patients with wide respiratory pressure swings. An alternative is offered by a fluid challenge. Studies have gathered data supporting infusion of 500 mL or 7 mL/kg saline and a PAWP of 18 mm Hg as a diagnostic cutoff. The procedure is simple and does not take much catheterization laboratory time. Combining echocardiography with invasive measurements may increase the diagnostic accuracy of diastolic dysfunction. Cardiac output after a fluid challenge may be of prognostic relevance.

Identifiants

pubmed: 32805242
pii: S0012-3692(20)32205-4
doi: 10.1016/j.chest.2020.08.019
pii:
doi:

Substances chimiques

Sodium Chloride 451W47IQ8X

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-797

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Michele D'Alto (M)

Department of Cardiology, Monaldi Hospital - University "L. Vanvitelli," Naples, Italy.

David Badesch (D)

Divisions of Pulmonary Sciences and Critical Care Medicine and Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO.

Eduardo Bossone (E)

Department of Cardiology, A. Cardarelli Hospital, Naples, Italy.

Barry A Borlaug (BA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

Evan Brittain (E)

Department of Medicine and Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN.

Marc Humbert (M)

Université Paris-Saclay, INSERM UMR_S 999, Department of Respiratory and Intensive Care Medicine, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.

Robert Naeije (R)

Department of Pathophysiology, Free University of Brussels, Brussels, Belgium. Electronic address: rnaeije@ulb.ac.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH